Follicular lymphoma (FL) results fromthe accumulation of malignant germinal center (GC) B cells leading to the development of an indolent and largely incurable disease. FL cells remain highly dependent on B-cell receptor (BCR) signaling and on a specific cell microenvironment, including T cells, macrophages, and stromal cells. Importantly, FL BCR is characterizedby aselectivepressure toretainsurfaceimmunoglobulinM(IgM)BCRdespite an active class-switch recombination process, and by the introduction, in BCR variable regions, of N-glycosylation acceptor sites harboring unusual high-mannose oligosaccharides. However, the relevance of these 2 FL BCR features for lymphomagenesis remains unclear. In this study, we demonstrated that IgM+ FL B cells activated a stronger BCR signaling network than IgG+ FL B cells and normal GC B cells. BCR expression level and phosphataseactivity could bothcontribute tosuchheterogeneity.Moreover,weunderlined that a subset of IgM+ FL samples, displaying highly mannosylated BCR, efficiently bound dendritic cell-specific intercellular adhesionmolecule-3-grabbing nonintegrin (DC-SIGN), which could in turn trigger delayed but long-lasting BCR aggregation and activation. Interestingly, DC-SIGN was found within the FL cell niche in situ. Finally, M2macrophages induced a DC-SIGN-dependent adhesion of highly mannosylated IgM+ FL B cells and triggered BCR-associated kinase activation. Interestingly, pharmacologic BCR inhibitors abolished such crosstalk between macrophages and FL B cells. Altogether, our data support animportant role forDC-SIGN-expressing infiltrating cells in the biology of FL and suggest that they could represent interesting therapeutic targets.
CITATION STYLE
Amin, R., Mourcin, F., Uhel, F., Pangault, C., Ruminy, P., Dupré, L., … Tarte, K. (2015). DC-SIGN-expressing macrophages trigger activation of mannosylated IgM B-cell receptor in follicular lymphoma. Blood, 126(16), 1911–1920. https://doi.org/10.1182/blood-2015-04-640912
Mendeley helps you to discover research relevant for your work.